Lucid Diagnostics (LUCD) Enterprise Value (2020 - 2026)
Lucid Diagnostics (LUCD) posted Enterprise Value of -$27.9 million for Q1 2026, up 19.68% on a QoQ basis from -$34.7 million in Q4 2025, and down 10.45% year-over-year from -$31.1 million in Q1 2025.
Lucid Diagnostics (LUCD) Enterprise Value (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Enterprise Value history runs 7 years deep, the most recent figure standing at -$27.9 million for Q1 2026.
- Quarterly Enterprise Value fell 10.45% year-over-year to -$27.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$27.9 million (down 10.45% YoY) and the FY2025 annual result came in at -$34.7 million, down 55.22% from the prior year.
- Enterprise Value was -$27.9 million for Q1 2026 at Lucid Diagnostics, up from -$34.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$14.5 million in Q3 2024 and bottomed at -$47.9 million in Q1 2022.
- A 5-year average of -$29.3 million and a median of -$26.9 million in 2022 frame the typical range for Enterprise Value.
- Peak annual rise in Enterprise Value reached 58.11% in 2022, while the deepest fall reached 126137.35% in 2022.
- Lucid Diagnostics' Enterprise Value stood at -$22.5 million in 2022, then increased by 15.92% to -$18.9 million in 2023, then declined by 18.32% to -$22.4 million in 2024, then slumped by 55.22% to -$34.7 million in 2025, then climbed by 19.68% to -$27.9 million in 2026.
- Business Quant data shows LUCD's Enterprise Value at -$27.9 million in Q1 2026, -$34.7 million in Q4 2025, and -$47.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -3.09 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.07 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -577.00 Mn |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -27.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.88 Mn |
| Dec 31, 2025 | -34.71 Mn |
| Sep 30, 2025 | -47.33 Mn |
| Jun 30, 2025 | -31.12 Mn |
| Mar 31, 2025 | -25.24 Mn |
| Dec 31, 2024 | -22.36 Mn |
| Sep 30, 2024 | -14.49 Mn |
| Jun 30, 2024 | -24.92 Mn |
| Mar 31, 2024 | -24.77 Mn |
| Dec 31, 2023 | -18.90 Mn |
| Sep 30, 2023 | -24.05 Mn |
| Jun 30, 2023 | -32.57 Mn |
| Mar 31, 2023 | -39.52 Mn |
| Dec 31, 2022 | -22.47 Mn |
| Sep 30, 2022 | -26.93 Mn |
| Jun 30, 2022 | -32.68 Mn |
| Mar 31, 2022 | -47.92 Mn |
| Dec 31, 2021 | -53.66 Mn |
| Sep 30, 2021 | -21,336.00 |
| Jun 30, 2021 | -2.23 Mn |